Deficits in arousal and stress responsiveness span numerous psychiatric developmental disorders including depression and anxiety. Arousal is supported by norepinephrine (NE) released from locus coeruleus (LC) neurons onto cortical and limbic areas. During development, the NE system matures in concert with increased exploration of the animal's environment. While several psychiatric medications target the LC-NE system, the possibility that its modulation during discreet developmental periods can have long-lasting consequences for mental health has not been explored. We used a pharmacogenetic strategy in mice to reversibly inhibit NE signaling during brief developmental periods to determine the long-lasting impact on adult circuits mediating emotional behavior. We also examine whether disruption of NE signaling during development results in permanent changes within the adult LC-NE system. Finally, we test whether developmental exposure to the α-2 receptor agonist guanfacine recapitulates the effect seen with our pharmacogenetic strategy. Our results reveal a sensitive period (postnatal days 10-21) during which alterations in NE signaling result in long-term changes in adult emotional behavior. Changes in NE signaling during this sensitive period results in changes in stress-related LC neuron activity, alterations in α-2 autoreceptor function, and circuit-specific molecular changes in LC-NE target regions in adulthood. Treating animals with guanfacine during the sensitive period produced similar results. Our findings indicate an early critical role for NE in sculpting brain circuits that support adult emotional function.
Introduction
The locus coeruleus (LC), a small densely packed brain stem nucleus, is the primary source of norepinephrine (NE) in the brain (Sara, 2009 ). The LC-NE system is involved in a wide range of normal behavioral and physiological responses such as arousal (Sara, 2009; Carter et al., 2010; Snyder et al., 2012) and is a major component of the centrally mediated stress response (Valentino and Van Bockstaele, 2008; Olson et al., 2011) . Behaviors supported by normal LC-NE function are disrupted numerous psychiatric disorders (Schwarz and Luo, 2015) .
Indeed, dysregulation within the NE system has been implicated in the pathophysiology and treatment of anxiety and depression (Goddard et al., 2010) .
For example, α-2 receptor agonists and antagonists alleviate or exacerbate anxiety symptoms respectively (Charney, 2003) . Moreover, fewer NE transporters (NET) have been reported in the LC of post-mortem brain tissue obtained from depressed patients (Klimek et al., 1997; Cottingham and Wang, 2012) . Together, this evidence implicates LC dysfunction in the biology of neuropsychiatric conditions. The ability of NE to modulate brain functions develops postnatally as the maturing LC begins to exhibit activity in response to environmental changes (Nakamura et al., 1987) . For example, LC-NE signaling is critical for early life sensory and odor-based attachment learning (Rangel and Leon, 1995; Raineki et al., 2010) . These processes are complete by postnatal day 10-15 (P10-P15), just as LC autoinhibition through α-2A autoreceptors comes online (Murrin et al., 2007; Raineki et al., 2010) . Interestingly, in rodents, the time period that follows (P15-P21) coincides with the emergence of normal exploration and habituation (Ba and Seri, 1995) . These and other milestones of LC function occur in the context of steadily increasing NE from birth until P30-40 when adult concentrations are reached (Loizou and Salt, 1970; Konkol et al., 1978; Morris et al., 1980) . Genetic models also support the notion that disrupting NE signaling has developmentally distinct consequences. While α-2A receptor KO mice display an anxiety and depression-like phenotype (Schramm et al., 2001; Lahdesmaki et al., 2002) , adult suppression of LC α-2A autoreceptors leads to the opposite outcome (Shishkina et al., 2002) . Moreover, drugs that target the NET for the treatment of depression are ineffective in juveniles but highly effective in adults (Geller et al., 1999; Hazell et al., 2000) , suggesting that the effects of modulating NE signaling on emotion related circuits differ across the lifespan. Thus, given that NE has distinct roles in circuit maturation, we hypothesized that briefly disrupting NE function during different developmental periods would have distinct consequences.
Here, we tested whether disruption of normal NE signaling during brief developmental time periods has long-term consequences for normal adult NE function in the brain. We found that pharmacogenetic inhibition of NE signaling during P10-P21, but not earlier or later resulted in molecular adaptations within the LC-NE system along with a depression-like phenotype with some anxiety features.
Administration of the α-2A agonist guanfacine, a medication commonly used in children, during this sensitive period phenocopied the pharmacogenetic results highlighting the potential vulnerability of developing brain systems to psychoactive medications.
Materials and Methods
Detailed information on experimental procedures is provided in Supplementary Information.
Generation of DBH-hM4Di mice
RC::PDi (Cre-dependent inhibitory DREADD [hM4Di] receptor) mice have been described (Ray et al., 2011) and were a generous gift from Susan Dymecki.
Tg(Dbh-cre)KH212Gsat/Mmcd (DBH-Cre) mice, identification number 032081-UCD, were obtained from the Mutant Mouse Regional Resource Center, a NCRR-NIH funded strain repository, and was donated to the MMRRC by the NINDS funded GENSAT BAC transgenic project. RC::PDi and DBH-Cre lines were crossed to generate the DBH-Cre-RC::PDi line (DBH-hM4Di+), which was maintained on a mixed C57BL/6 and 129S6/Sv background.
Drug treatment and administration
Clozapine-N-oxide (CNO): CNO was obtained from the NIH as part of the Rapid Access to Investigative Drug Program funded by the NINDS. For adult acute administration, CNO was injected at a dose of 5 mg/kg in 1% DMSO in 0.9% saline intraperitoneally (i.p.).
For developmental interventions, DBH-hM4Di
+ male mice were treated daily with vehicle or CNO i.p. (5 mg/kg in 1% DMSO and 0.9% saline) during different time windows (P2-P9/ P10-P21/ P33-P45/ P56-P67). Specifically, 10 µL per 1 gr of mouse body weight was injected from a 0.5 mg/mL stock solution. For pre-weaning treatments (P21), the entire litters were removed from dams and placed in a small tray containing bedding from the respective home cage. The tray was placed on a scale allowing us to measure the weight of an individual pup when removing it for injection. Mice were injected in a random order and immediately placed back in the home cage. All mice within a litter were assigned to the same treatment.
Systemically induced adult hypothermia: clonidine (0.5 mg/kg in 0.9% saline) and 8-OH-DPAT (1 mg/kg in 0.9% saline) (Sigma-Aldrich, St. Louis, MO) (Richardson-Jones et al., 2011) were administered i.p.
Guanfacine: 1 mg/kg/day in 0.9% saline was administered i.p.
Behavioral and physiological studies
13-15-week-old male mice were tested over 4-5 weeks. Anxiety tests were completed before other behavioral tests.
Open-field test
Exploration of a novel open field was measured for 30 min as previously described (Garcia-Garcia et al., 2015; Garcia-Garcia et al., 2017) . The center of the arena was defined as a square area occupying the center 50% of the total arena. Dependent measures were total path length (cm) and percent distance in the center (distance travelled in the center divided by the total distance travelled).
Elevated-plus maze
Animals were placed into the central area facing one open arm and allowed to explore the maze for 5 min as previously described (Garcia-Garcia et al., 2015; Garcia-Garcia et al., 2017) 
Sucrose Preference
An 8-day sucrose preference protocol was performed as previously described (Garcia-Garcia et al., 2015; Garcia-Garcia et al., 2017) . On days 1 and 2, mice were presented with two water filled bottles (water/water) for 2 h and 1 h respectively. On days 3 and 4, both bottles contained 1% sucrose in water (sucrose/sucrose) for 1 h and 30 min respectively. On choice days 5-8 (testing days), one bottle contained water and the other 1% sucrose solution for 30 min each day (water/sucrose). Daily preference was calculated as: ((weight bottle 1)/ (weight bottles (1 + 2)) ×100).
Forced-swim test
Behavioral response to forced swimming was assayed as described previously (Garcia-Garcia et al., 2015; Garcia-Garcia et al., 2017) . Mice were placed into clear plastic buckets 20 cm in diameter and 23 cm deep filled 2/3 of the way with 26°C water and videotaped from the side for 6 min. Only the last 4 minutes were scored. Scoring was done using an automated Viewpoint Videotrack software package (Montreal, Canada), which was validated before by manual scoring. Dependent variable was immobility.
Hypothermia
Mice were singly housed in clean cages for an hour and three baseline temperatures were taken (-60 min, -30 min, 0min). Immediately after the last baseline measurement (0 min), animals received CNO or clonidine as described above. Body temperature was assessed rectally using a lubricated probe (Thermalert TH-5 thermal monitor, Physitemp, Clifton, NJ) every 10 min for 60 or 120 minutes.
Corticosterone measurements
Blood was collected during the dark-light transition and 12 hours later during the light-dark transition as previously described (Garcia-Garcia et al., 2015; GarciaGarcia et al., 2017) . For stress-evoked corticosterone, experiments were performed starting at 12.00. Mice were exposed to a forced swim stressor for 6 min and blood was drawn from the submandibular vein 12 min later. Blood was centrifuged and plasma was isolated and stored until processed. Corticosterone levels were assessed by ELISA from plasma samples (Enzo Life Sciences, Farmingdale, NY) (Garcia-Garcia et al., 2015; Garcia-Garcia et al., 2017) .
C-fos Immunohistochemistry
C-fos was induced as previously described by a forced swim stressor (Garcia-Garcia et al., 2017) . After tissue processing, LC sections were stained using rabbit anti-c-fos antibody (1:5000, Millipore) and sheep anti-tyrosine hydroxylase (TH) (1:1000, Abcam) as previously described (Garcia-Garcia et al.,
2017).

Quantitative PCR
Total RNA was extracted using TRIzol and SuperScript® III First-Strand Synthesis System was used to synthesize cDNA, and PCR was performed and quantified using SYBR Green real-time PCR Master Mix (Life Technologies, Grand
Island, NY). Primers used in the real-time qPCR are in the supplemental information.
Brain neurotransmitter levels
NE concentrations were determined by HPLC as previously described (Garcia-Garcia et al., 2015) . Specifically, all assays were carried out on a Waters
Xevo TQ MS ACQUITY UPLC system (Waters, Milford, MA, USA). Concentrations of compounds in the samples were quantified by comparing integrated peak areas against those of known amounts of purified standards. Loss during extraction was accounted for by adjusting for the recovery of the internal standard added before extraction. The results were normalized by sample weight.
Statistical Analysis
All statistical analyses were performed using Stat View (SAS Institute Inc.).
Final group numbers are shown in the figure legends. The results were expressed as mean ± SEM. p<0.05 was used as the threshold for significance. Group differences were analyzed using a one-way analysis of variance (ANOVA) unless otherwise stated. Repeated measures ANOVA was used for hypothermia and sucrose preference experiments.
Results
Manipulation of NE Neuronal Activity via Conditional Expression of DREADDs in Mice
To interfere with NE signaling in vivo, we crossed RC::PDi mice (Ray et al., 2011 ) to a dopamine β-hydroxylase cre line (DBH-Cre) (Gong et al., 2007) . The resulting DBH-cre;RC:PDi (DBH-hM4Di + ) mice express hemaglutinin (HA) tagged hM4Di (inhibitory DREADD) in NE neurons ( Figure 1A , B). LC immunostaining against Tyrosine hydroxylase (TH) and HA confirmed selective DREADD expression in virtually all LC-NE neurons ( Figure 1B ). This approach allows for targeted and time limited inhibition of NE neurons by activation of hM4Di with the biologically inert synthetic ligand CNO (Armbruster et al., 2007) .
We next took advantage of the fact that α2-A receptor agonists cause a modest hypothermia in adult animals by inhibiting NE neurons (Madden et al., 2013) . We thus tested whether CNO injection would also cause hypothermia by inhibiting NE neurons. Indeed, administration of CNO (5 mg/kg) but not vehicle resulted in sustained hypothermia in adult DBH-hM4Di + mice. No effect was seen in DBH-hM4Di -mice treated with vehicle or CNO ( Figure 1C ). This result demonstrates that hM4Di receptors expressed in NE neurons are functional.
Repeated pharmacogenetic inhibition of NE neurons between P10 and P21 results in increased anxiety in the open-field and depression-like behavioral phenotype later in life.
We next hypothesized that normal NE function in early development is critical to establish later behavioral responses. We tested this by disrupting NE function through daily administration of CNO (5 mg/kg) to DBH-hM4Di + mice during three discrete postnatal developmental periods ( Figure 2A ). The LC exhibits bursts of activity in response to external stimulation by the first week of life (Nakamura et al., 1987) . Between P10 and weaning (P21), robust spontaneous LC firing emerges and α-2A receptor negative feedback is established (Happe et al., 2004) .
We therefore selected P2-P9, P10-21, and an adult reference period (P56-P67) for our experimental manipulations.
To assess the effects of CNO treatment on exploration and anxiety later in life, we first tested the treated animals at 13-15 weeks of age in the open-field test.
Adult DBH-hM4Di + mice treated with CNO during P10-P21 but not during the other from its respective controls. Importantly, no differences in CORT levels were detected during the diurnal cycle (Supplementary Figure 1D-F) .
While robust spontaneous LC activity emerges during the later pre-weaning period, adult NE levels are not reached until adolescence, during the fifth week of life (Murrin et al., 2007) . We therefore asked whether animals that underwent NE neuron inhibition during adolescence (P33-P45) would more closely resemble adult-or the juvenile-treated animals with regards to behavioral and physiological consequences. However, CNO treatment during P33-P45 revealed no change in anxiety-like behaviors, depression-related behaviors or stress-induced CORT (Supplementary Figure 2A-H) .
Transient inhibition of NE neurons between P10-P21 has long lasting effects on stress-induced LC-NE neuronal activation
Having observed that interfering with normal NE signaling in the P10-P21
time period results in sustained changes in behavioral and physiological reactivity, we tested whether we could detect sustained changes in the response properties of the LC-NE neurons. To do so, we evaluated c-fos expression in the LC of adult animals in response to a forced-swim stressor. We detected fewer c-fos positive 
Inhibition of NE neurons between P10-P21 interferes with α2-A mediated hypothermia in adults.
α2-A receptors are the predominant autoreceptors on LC-NE neurons that provide negative feedback to the LC and common heteroreceptors that mediate responses to secreted NE (Langer, 2015) . To assess α2-A receptor function in adulthood, mice were acutely treated with the α2-A receptor agonist clonidine, and their core body temperature was measured. Interestingly, only mice treated with CNO during P10-P21, displayed an attenuated hypothermic response when compared to their controls (Supplementary Figure 4A-C) . Next, to ensure that the observed changes in thermoregulation were not the result of adaptation in the serotonin system we systemically injected the 5-HT 1A agonist 8-OH-DPAT, as 5-HT 1A agonist are well known to generate hypothermic responses (Ray et al., 2011) .
We observed an acute hypothermic response and no differences seen between CNO and vehicle treated groups (Supplementary Figure 4D) . These results indicate that interfering with NE activity P10-P21, but not during other periods (P2-P9, P56-P67) results in long-term changes in the sensitivity of α2-A receptors.
Inhibition of NE neurons between P10-P21 leads to long-term molecular adaptations in the adult LC-NE circuit.
Identification of physiological changes in response to an α2-A agonist in adults from only the P10-P21 cohort suggested long-term adaptations within the NE circuitry. We therefore decided to examine the expression of genes critical to NE signaling and regulation in this developmental group and in the reference adult We next examined expression levels of NE receptors in LC projection areas that receive extensive NE innervation and have been implicated in the behaviors tested in our earlier studies. Specifically, the prefrontal cortex (PFC), hippocampus, hypothalamus and amygdala were selected. We found that interfering with NE neuronal activity during P10-P21, but not during P56-67, resulted in decreased expression of α2-A and α1-D (ADRA1D) in the PFC ( Figure 4D -F) and decreased α2-A and α1-A (ADRA1A) receptor mRNA levels in the hippocampus ( Figure 4G-I) of adult animals. In contrast, the expression of these receptors appeared unchanged in the hypothalamus and amygdala for both the P10-P21 and the P56-67 cohorts (Supplementary Figure 5A-F) . Thus, changes to key components of the NE circuit were evident in select target areas in adult animals that were treated with CNO between P10-P21, but not in animals treated in adulthood.
Having observed altered mRNA expression of NE receptors, we assessed NE levels in the same brain regions in mice that were exposed to the P10-P21
intervention. We micro-dissected the LC, the PFC, the hippocampus, the hypothalamus and the amygdala to measure total NE content in each region by HPLC. Interestingly, NE content was decreased in the PFC of P10-P21 CNOtreated when compared to vehicle-treated mice ( Figure 4K ). No such changes were observed in the LC, hippocampus, hypothalamus or amygdala ( Figure 4J , L and Supplementary Figure 5I , J). In addition, no differences were detected in serotonin or dopamine levels in these brain regions between CNO or vehicletreated animals (Data not shown).
Administration of the α2-A receptor agonist, guanfacine, during p10-P21, phenocopies the adult behavioral effects of suppressing NE neuron activity at that time.
One important developmental milestone in the NE circuit is the rapid rise of firing rates and the establishment of α-2A receptor mediated negative feedback during P10-P21 (Murrin et al., 2007) . Given the extensive changes in α2-A receptor expression and function that we observed in the P10-P21 group treated with CNO, we tested whether stimulation of the α2-A receptor during this time would phenocopy our findings. We decided to use Guanfacine, which is an α2-A agonist that is routinely prescribed in children and adolescents to treat attention deficit hyperactivity disorder (ADHD) (Langer, 2015) .
Mice were treated with guanfacine (1 mg/kg) from either P10-P21 or P56-P67 as a reference period ( Figure 5A ). Adult mice treated with guanfacine during P10-P21, but not P56-P67, displayed decreased percent center distance (
Figure 5B 
Discussion
Our results demonstrate the existence of a developmental sensitive period between P10 and P21, during which disruption of NE signaling leads to enduring adult behavioral phenotypes relevant to depression and anxiety. Inhibition of NE signaling using the DREADD system prior to this time (P2-P9) does not result in a long-term behavioral phenotype. Interestingly, this developmental window is characterized by an immature LC that has limited spontaneous activity and a robust and prolonged physiological response to environmental stimuli (Nakamura et al., 1987; Murrin et al., 2007; Raineki et al., 2010) . In turn, the P10-P21 period is characterized by emergence of spontaneous activity and a potent α2-A autoreceptor mediated negative feedback (Murrin et al., 2007) .
Nevertheless, the LC continues to mature past P21 as NE levels steadily increase until plateauing near adult levels in early adolescence (Murrin et al., 2007) . This stabilization of LC function corresponds to our results that by P33
interfering with NE neuronal firing no longer had enduring sequelae. This is further supported by negative results in our P56-P67 cohort. As a result, our data suggest that there is a complex interplay between the emergence of spontaneous NE neuronal activity, the establishment of LC negative feedback and baseline NE levels, which ultimately results in determining adult emotion-like behaviors. The fact that we did not detect behavioral changes in the adolescent and early adulthood interventions, suggests that once mature, the NE system is sufficiently stable to withstand short-term perturbations without eliciting the long-term adaptations seen during P10-P21.
Molecular interrogation of NE machinery in the P10-P21 cohort revealed distinct alterations in the LC and its target regions. The LC was broadly affected including reduced mRNA levels for the rate limiting synthesis enzyme DBH, the reuptake transporter NET, and the inhibitory α2-A autoreceptor responsible for feedback inhibition. In this regard, the absence of change in basal NE levels in the LC raises the possibility that interfering with LC firing during the sensitive period changes LC ability to mount stress responses. Our results indicating that fewer LC TH neurons express c-fos following stress, support this possibility. Furthermore, a change in LC reactivity would be expected to be accompanied by molecular adaptations in NE target regions. Indeed, molecular NE machinery in some LC target regions, such as the PFC, but not others was permanently altered.
LC projects throughout the neocortex and the limbic structures. Remarkably we saw no adaptations in α-adrenergic receptor expression in the amygdala or the hypothalamus. The hypothalamus receives substantial NE innervation from the medullary catecholamine nuclei and the ventral tegmentum rather than solely the LC (Moore and Bloom, 1979; Palkovits et al., 1979; Sawchenko and Swanson, 1982) raising the possibility that the P10-P21 sensitive period is particular to LC NE neurons. This possibility is further supported by our observation that the amygdala, which receives NE inputs from the lateral tegmentum (Moore and Bloom, 1979) , did not exhibit molecular changes. In contrast, the hippocampus and the PFC exhibited a robust reduction in α2-A receptor expression. Ascending NE fibers arising from regions other than the LC terminate prior to reaching the hippocampus and the neocortex, which receive their robust innervation from the LC (Moore and Bloom, 1979) . Interestingly, only the PFC exhibited a long-lasting decrease in baseline NE suggesting a shift in a homeostatic set point for NE signaling. While it is difficult to infer how different NE levels in the hippocampus and the PFC may translate to behaviors, PFC neuronal activity encodes FST behavioral states and modulates anhedonic behaviors (Warden et al., 2012; Ferenczi et al., 2016) .
Together the results highlight circuit specific changes that are associated with depression-related but also with some anxiety-related features following inhibition of NE function during a sensitive period.
NE-acting medications are part of the pharmacological arsenal used to treat psychiatric disorders in children. In particular, guanfacine have been used for treating ADHD (Lee, 1997) and clonidine for post-traumatic stress disorder (Harmon and Riggs, 1996) . Our studies highlight the critical need to fully understand the implications of treating developing brains with pharmacologic agents targeting modulatory amines. There has been relatively little research on drug by development interactions but given the potential long-term consequences of treatments during sensitive periods, additional consideration by physicians prescribing psychoactive medications to young children seems warranted. but not other groups when comparing CNO to vehicle mice (one-way ANOVA for See also Supplementary Figure 1 and 2. 
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